Clinical Trial Update: Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD) [Phase 3]

View source ↗

Summary

Phase 3 trial of anecortave acetate for exudative age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• anecortave acetate (anecortave acetate)

Snippet

Sponsor: Alcon Research | Conditions: Macular Degeneration | Phase 3 | Status: COMPLETED